Clinical Study
The Experience in Nicaragua: Childhood Leukemia in Low Income Countries—The Main Cause of Late Diagnosis May Be “Medical Delay”
Table 1
Time intervals from first symptoms to diagnosis of leukemia.
| | Managua | Monza | value |
| Lag time from first symptoms to diagnosis (days) | | | | Median, (IQR) | 29 (18–44) | 14 (9–24) | # | ALL | 29,5 (18–45) | 15 (9–27) | # | AML | 21 (18–39) | 9 (6–20) | # |
| Patient delay (days) | | | | Median, (IQR) | 7 (1,5–15) | 5 (1–13) | # | ALL | 7 (1,5–15) | 5,5 (1–13) | # | AML | 6 (3–11) | 4 (2–13) | # |
| Physician delay (days) | | | | Median, (IQR) | 16.5 (7–33,5) | 7 (2–4) | # | ALL | 16 (7–33) | 8 (2–15) | # | AML | 18 (6–33) | 3 (1–6) | # |
| Lag time to diagnosis: “0–30 days” and “>30 days” groups | | | | Lag time to diagnosis “>30 days” (frequencies) | 37 (45.7%) | 15 (18.5%) |
°
| Lag time to diagnosis “0–30 days” (frequencies) | 44 (54.3%) | 66 (81.5%) |
|
|
°
: Chi-square test; #: Mann-Whitney/Wilcoxon Two-Sample Test; ALL: acute lymphoblastic leukemia; AML: acute myeloid leukemia.
|